Gambling in the deep sea

REFERENCES Chisari FV (2005) Unscrambling hepatitis C virus–host interactions. Nature 436: 930–932 Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359–362 De Francesco R, Migliaccio G (2005) Challenges and successes in developing new therapies for hepatitis C. Nature 436: 953–960 Feld JJ, Hoofnagle JH (2005) Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436: 967–972 Fleckenstein J (2004) Chronic hepatitis C in African Americans and other minority groups. Curr Gastroenterol Rep 6: 66–70 Hinrichsen H et al (2004) Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients. Gastroenterology 127: 1347–1355 Houghton M, Abrignani S (2005) Prospects for a vaccine against the hepatitis C virus. Nature 436: 961–966 Laffan G (2005) Dutch government urged to inform public of blood mistakes. Lancet 365: 2165 Lamarre D et al (2003) An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 426: 186–189 Larkin M (2000) WHO’s blood-safety initiative: a vain effort? Lancet 355: 1245 Lindenbach BD et al (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 623–626 Mercer DF et al (2001) Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7: 927–933 Meuleman P, Libbrecht L, De Vos R, de Hemptinne B, Gevaert K, Vandekerckhove J, Roskams T, Leroux-Roels G (2005) Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 41: 847–856 Reiser M et al (2005) Antiviral efficacy of NS3serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C. Hepatology 41: 823–835 Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558–567 Wakita T et al (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791–796 WHO (2000) Hepatitis C. www.who.int/ mediacentre/factsheets/fs164/en Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102: 9294–9299